Anthropic’s safety warnings may have just backfired — the government has pulled the plug on its most powerful AIJune 13, 2026
Amgen Turns to an Independent Review to Defend Rare Disease Drug in FDA CrosshairsNews DeskJune 12, 20260 Amgen is standing behind a rare disease drug that the FDA wants off the market due to safety concerns and…
Apogee’s Royalty Deal With Blackstone Will Fund Pivotal Test in Eczema and MoreNews DeskMay 27, 20260 Apogee Therapeutics’ lead drug candidate has new mid-stage data indicating it could be competitive with currently available biologic medicines for…